Our findings of CEBPA repression in IPF lung fibroblasts and the beneficial effects of restoring its expression on attenuating pro-fibrotic fibroblast activation (Fig. 2) suggest that pharmacological rescue of CEBPA expression may have therapeutic relevance. The gene discussed is CEBPA; the disease is idiopathic pulmonary fibrosis.